Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Other Operating Expenses: 2021-2024

Historic Other Operating Expenses for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Dec 2024 value amounting to $81.6 million.

  • Mirum Pharmaceuticals' Other Operating Expenses rose 22.74% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.8 million, marking a year-over-year increase of 12.96%. This contributed to the annual value of $81.6 million for FY2024, which is 73.56% up from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Other Operating Expenses stood at $81.6 million for FY2024, which was up 73.56% from $47.0 million recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Other Operating Expenses ranged from a high of $81.6 million in FY2024 and a low of $1.9 million during FY2021.
  • Its 3-year average for Other Operating Expenses is $47.0 million, with a median of $47.0 million in 2023.
  • Data for Mirum Pharmaceuticals' Other Operating Expenses shows a peak YoY spiked of 550.24% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Mirum Pharmaceuticals' Other Operating Expenses stood at $1.9 million in 2021, then surged by 550.24% to $12.4 million in 2022, then soared by 280.14% to $47.0 million in 2023, then surged by 73.56% to $81.6 million in 2024.